{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:17:41Z","timestamp":1787069861230,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["45\/2022\/869\/Sattar-4-2022\/001-70-4099-1-2022"],"award-info":[{"award-number":["45\/2022\/869\/Sattar-4-2022\/001-70-4099-1-2022"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.bbrep.2022.101350","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T04:30:59Z","timestamp":1663821059000},"page":"101350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["In silico prediction of COVID-19 cytokine storm in lung cancer types"],"prefix":"10.1016","volume":"32","author":[{"given":"Surabhi","family":"Suchanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Awasthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyanendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod K.","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7411-4022","authenticated-orcid":false,"given":"Rajeev","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbrep.2022.101350_bib1","article-title":"Clinical management of lung cancer patients during the outbreak of COVID-19 epidemic","author":"Wang","year":"2020","journal-title":"Infect. Agent. Cancer15"},{"key":"10.1016\/j.bbrep.2022.101350_bib2","doi-asserted-by":"crossref","DOI":"10.2147\/JIR.S301784","article-title":"Attenuating the effects of novel COVID-19 (SARS-CoV-2) infection-induced cytokine storm and the implications","volume":"14","author":"Rowaiye","year":"2021","journal-title":"J. Inflamm. Res."},{"issue":"4","key":"10.1016\/j.bbrep.2022.101350_bib3","doi-asserted-by":"crossref","DOI":"10.14336\/AD.2020.0520","article-title":"Multi-organ dysfunction in patients with COVID-19: a systematic review and meta-analysis","volume":"11","author":"Wu","year":"2020","journal-title":"Aging Dis"},{"issue":"10","key":"10.1016\/j.bbrep.2022.101350_bib4","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.3390\/jcm11102945","article-title":"Comparative study of cytokine storm treatment in patients with COVID-19 pneumonia using Immunomodulators","volume":"11","author":"Marc","year":"2022","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.bbrep.2022.101350_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry Depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bbrep.2022.101350_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-0868-6","article-title":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes","volume":"26","author":"Sungnak","year":"2020","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.bbrep.2022.101350_bib7","article-title":"Global cancer Statistics 2020: GLOBOCAN Estimates of Incidence and mortality worldwide for 36 cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA. Cancer J. Clin."},{"issue":"AUG","key":"10.1016\/j.bbrep.2022.101350_bib8","article-title":"Lung cancer: understanding its molecular pathology and the 2015 wHO classification","volume":"7","author":"Inamura","year":"2017","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbrep.2022.101350_bib9","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.13346","article-title":"Differentiated regulation of immune-response related genes between LUAD and LUSC subtypes of lung cancers","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrep.2022.101350_bib10","article-title":"Evaluation of the susceptibility and fatality of lung cancer patients towards the COVID-19 infection: a systemic approach through analyzing the ACE2, CXCL10 and their co-expressed genes","volume":"2","author":"Mahmood","year":"2021","journal-title":"Curr. Res. Microb. Sci."},{"key":"10.1016\/j.bbrep.2022.101350_bib11","article-title":"Severity of COVID-19 in patients with lung cancer: Evidence and challenges","volume":"3","author":"Passaro","year":"2021","journal-title":"J. Immunother. Cancer9"},{"issue":"May","key":"10.1016\/j.bbrep.2022.101350_bib12","article-title":"COVID-19 cytokine storm: the anger of inflammation","volume":"133","author":"Mahmudpour","year":"2020","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.bbrep.2022.101350_bib13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the Eye of the cytokine storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"6585","key":"10.1016\/j.bbrep.2022.101350_bib14","article-title":"The immunology and immunopathology of COVID-19","volume":"375","author":"Merad","year":"2022","journal-title":"Science (80)"},{"key":"10.1016\/j.bbrep.2022.101350_bib15","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the Renin-angiotensin system: Celebrating the 20th Anniversary of the discovery of ACE2","author":"Gheblawi","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrep.2022.101350_bib16","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19","volume":"1","author":"Ni","year":"2020","journal-title":"Crit. Care24"},{"issue":"3","key":"10.1016\/j.bbrep.2022.101350_bib17","doi-asserted-by":"crossref","DOI":"10.1007\/s12026-020-09137-5","article-title":"Covid 19: a clue from innate immunity","volume":"68","author":"Birra","year":"2020","journal-title":"Immunol. Res."},{"issue":"2","key":"10.1016\/j.bbrep.2022.101350_bib18","article-title":"Cytokine storm of covid-19 and its impact on patients with and without chronic liver disease","volume":"9","author":"Premkumar","year":"2021","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"50","key":"10.1016\/j.bbrep.2022.101350_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe3024","article-title":"Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm","volume":"6","author":"Mudd","year":"2020","journal-title":"Sci. Adv."},{"issue":"9","key":"10.1016\/j.bbrep.2022.101350_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.27068","article-title":"Cytokine storm in severe COVID-19 pneumonia","volume":"93","author":"G\u00fcrsoy","year":"2021","journal-title":"J. Med. Virol."},{"issue":"5","key":"10.1016\/j.bbrep.2022.101350_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(21)00127-2","article-title":"IL-6 blockade for COVID-19: a global scientific call to arms","volume":"9","author":"Murthy","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.bbrep.2022.101350_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-016-1028-7","article-title":"Comprehensive analyses of tumor immunity: implications for cancer immunotherapy","volume":"17","author":"Li","year":"2016","journal-title":"Genome Biol."},{"issue":"2","key":"10.1016\/j.bbrep.2022.101350_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2021.11.001","article-title":"Lung cancer and severe acute respiratory syndrome coronavirus 2 infection: Identifying important Knowledge Gaps for investigation","volume":"17","author":"Rolfo","year":"2022","journal-title":"J. Thorac. Oncol."},{"issue":"21","key":"10.1016\/j.bbrep.2022.101350_bib24","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."},{"issue":"20","key":"10.1016\/j.bbrep.2022.101350_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btz210","article-title":"TISIDB: an integrated repository portal for tumor-immune system interactions","volume":"35","author":"Ru","year":"2019","journal-title":"Bioinformatics"},{"issue":"6","key":"10.1016\/j.bbrep.2022.101350_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19063454","article-title":"Landscape of molecular Crosstalk Perturbation between lung cancer and COVID-19","volume":"19","author":"Kuchi","year":"2022","journal-title":"Int. J. Environ. Res. Public Health."},{"issue":"W1","key":"10.1016\/j.bbrep.2022.101350_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.bbrep.2022.101350_bib28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/nar\/gky310","article-title":"MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis","volume":"46","author":"Chong","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"April","key":"10.1016\/j.bbrep.2022.101350_bib29","first-page":"1","article-title":"The ACE2-deficient mouse: a model for a cytokine storm-driven inflammation","author":"Wang","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.bbrep.2022.101350_bib30","doi-asserted-by":"crossref","DOI":"10.1177\/0963689720968749","article-title":"ACE2 and TMPRSS2 potential involvement in Genetic susceptibility to SARS-COV-2 in cancer patients","volume":"29","author":"Ravaioli","year":"2020","journal-title":"Cell Transplant."},{"key":"10.1016\/j.bbrep.2022.101350_bib31","doi-asserted-by":"crossref","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality","volume":"55","author":"Zhang","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.bbrep.2022.101350_bib32","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cca.2020.06.017","article-title":"Cytokine storm induced by SARS-CoV-2","volume":"59","author":"Song","year":"2020","journal-title":"Clin. Chim. Acta509"},{"key":"10.1016\/j.bbrep.2022.101350_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The cytokine storm in COVID-19: an overview of the involvement of the chemokine\/chemokine-receptor system","volume":"53","author":"Coperchini","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"7","key":"10.1016\/j.bbrep.2022.101350_bib34","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S2665-9913(20)30120-X","article-title":"The immunology of COVID-19: is immune modulation an option for treatment?","volume":"2","author":"Zhong","year":"2020","journal-title":"Lancet Rheumatol"},{"issue":"10","key":"10.1016\/j.bbrep.2022.101350_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-020-00428-4","article-title":"The global response to the COVID-19 pandemic: how have immunology societies contributed?","volume":"20","author":"Osier","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.bbrep.2022.101350_bib36","article-title":"Immunology of COVID-19: current state of the science","author":"Vabret","year":"2020","journal-title":"Immunity52"},{"issue":"4","key":"10.1016\/j.bbrep.2022.101350_bib37","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.bbrep.2022.101350_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18319-6","article-title":"Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor","volume":"11","author":"Yang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrep.2022.101350_bib39","first-page":"941","article-title":"The angiotensin-converting enzyme 2 in tumor growth and tumor-associated angiogenesis in non-small cell lung cancer","volume":"23","author":"Feng","year":"2010","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.bbrep.2022.101350_bib40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2478\/jtim-2020-0003","article-title":"Potential role of ACE2 in coronavirus disease 2019 (COVID-19) prevention and management","volume":"8","author":"Liu","year":"2020","journal-title":"J. Transl. Intern. Med."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580822001509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580822001509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:50:16Z","timestamp":1762501816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580822001509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":40,"alternative-id":["S2405580822001509"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2022.101350","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico prediction of COVID-19 cytokine storm in lung cancer types","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2022.101350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101350"}}